Linda Burkly is EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine, Inc.. Currently has a direct ownership of 64,398 shares of EDIT, which is worth approximately $147,471. The most recent transaction as insider was on Jul 31, 2025, when has been sold 5,121 shares (Common Stock) at a price of $2.49 per share, resulting in proceeds of $12,751. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 64.4K
8.32% 3M change
11.95% 12M change
Total Value Held $147,471

Linda Burkly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 31 2025
SELL
Open market or private sale
$12,751 $2.49 p/Share
5,121 Reduced 7.37%
64,398 Common Stock
Jun 03 2025
SELL
Open market or private sale
$1,248 $1.72 p/Share
726 Reduced 1.03%
69,519 Common Stock
Mar 04 2025
SELL
Open market or private sale
$4,943 $1.71 p/Share
2,891 Reduced 3.95%
70,245 Common Stock
Jul 25 2024
SELL
Open market or private sale
$64,422 $5.42 p/Share
11,886 Reduced 13.98%
73,136 Common Stock
Mar 02 2024
BUY
Grant, award, or other acquisition
-
39,855 Added 31.92%
85,022 Common Stock
Jul 24 2023
BUY
Grant, award, or other acquisition
-
45,167 Added 50.0%
45,167 Common Stock
LB

Linda Burkly

EVP, CHIEF SCIENTIFIC OFFICER
Cambridge, MA

Track Institutional and Insider Activities on EDIT

Follow Editas Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDIT shares.

Notify only if

Insider Trading

Get notified when an Editas Medicine, Inc. insider buys or sells EDIT shares.

Notify only if

News

Receive news related to Editas Medicine, Inc.

Track Activities on EDIT